ACTH Deficiency, Higher Doses of Hydrocortisone Replacement, and Radiotherapy Are Independent Predictors of Mortality in Patients with Acromegaly
The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Context A number of retrospective studies report that patients with acromegaly have increased morbidity and premature mortality, with standardized mortality ratios (SMR) of 1.3-3. Many patients with acromegaly develop hypopituitarism as a result of the pituitary adenoma itself or therapies such as surgery and radiotherapy. Pituitary radiotherapy and hypopituitarism have also been associated with an increased SMR. Methods Using the West MIDLANDS: Acromegaly database (n = 501; 275 female), we assessed the influence of prior radiotherapy and hypopituitarism (and replacement therapy) on mortality in patients with acromegaly. Median duration of follow-up was 14.0 yr (interquartile range, 7.9-21 yr). Results All-cause mortality was elevated [SMR, 1.7 (1.4, 2.0); P Conclusions Radiotherapy and ACTH deficiency are significantly associated with increased mortality in patients with acromegaly. In ACTH-deficient patients, a daily dose of more than 25 mg hydrocortisone is associated with increased mortality compared to lower doses. These results have important implications for the treatment of patients with acromegaly and also raise issues as to the optimum hydrocortisone treatment regimens for ACTH-deficient patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Higher GC replacement doses in patients with ACTH deficiency are associated with increased overall and cardiovascular mortality; the greatest risk is in patients receiving daily HC doses higher or equal to 30 mg (8).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [8]
In the citing paper
“Higher GC replacement doses in patients with ACTH deficiency are associated with increased overall and cardiovascular mortality; the greatest risk is in patients receiving daily HC doses higher or equal to 30 mg (8).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [8]
In the citing paper
“It has become increasingly evident that, even in patients with treated AI, there continues to be significant morbidity and reduced life expectancy.5–7”
From Adrenal crisis: prevention and management in adult patients (2019) · cites this paper as [6]
Citations
Cites
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0022 · Cited by 1,309
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
Self-citation11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
Self-citationMortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study1
Orme, S. M., McNally, R. J. Q., Cartwright, R. A., & Belchetz, P. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5007 · Cited by 805
Statistical methods in cancer research
Gardner, B. (2001) · Journal of Surgical Oncology · doi:10.1002/jso.1170 · Cited by 777
Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease
Wei, L., MacDonald, T. M., & Walker, B. R. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00007 · Cited by 730
Factors Influencing Mortality in Acromegaly
Holdaway, I. M., Rajasoorya, R. C., & Gamble, G. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031199 · Cited by 651
Morbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622
Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly1
Swearingen, B., Barker, F. G., Katznelson, L., Biller, B. M. K., Grinspoon, S., Klibanski, A., Moayeri, N., Black, P. M., & Zervas, N. T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5222 · Cited by 586
Increased cerebrovascular mortality in patients with hypopituitarism
Bülow, B., Hagmar, L., Mikoczy, Z., Nordström, C., & Erfurth, E. M. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.d01-1749.x · Cited by 542
Wright, A. D., Hill, D. M., Lowy, C., & Fraser, T. R. (1970) · PubMed · Cited by 529
Mortality in Acromegaly: A Metaanalysis
Dekkers, O. M., Biermasz, N. R., Pereira, A. M., Romijn, J. A., & Vandenbroucke, J. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1191 · Cited by 517
Premature Mortality in Patients with Addison’s Disease: A Population-Based Study
Bergthorsdottir, R., Leonsson-Zachrisson, M., Odén, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0076 · Cited by 490
Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
ESTEBAN, N. V., LOUGHLIN, T., YERGEY, A. L., ZAWADZKI, J. K., BOOTH, J. D., WINTERER, J. C., & LORIAUX, D. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-39 · Cited by 481
The effect of hypopituitarism on life expectancy.
Bates, A. S., Van't Hoff, W., Jones, P. J., & Clayton, R. N. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772595 · Cited by 475
Self-citationAn audit of outcome of treatment in acromegaly
(1993) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068816 · Cited by 466
Self-citationHypopituitarism Following External Radiotherapy for Pituitary Tumours in Adults
LITTLEY, M. D., SHALET, S. M., BEARDWELL, C. G., AHMED, S. R., APPLEGATE, G., & SUTTON, M. L. (1989) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068308 · Cited by 444
Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly
Swearingen, B. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.10.3419 · Cited by 400
Minniti, G., Traish, D., Ashley, S., Gonsalves, A., & Brada, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1152 · Cited by 377
Ayuk, J., Clayton, R. N., Holder, G., Sheppard, M. C., Stewart, P. M., & Bates, A. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031584 · Cited by 343
Self-citationFilipsson, H., Monson, J. P., Koltowska-Häggström, M., Mattsson, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0524 · Cited by 321
Long‐term outcome and mortality after transsphenoidal adenomectomy for acromegaly
Beauregard, C., Truong, U., Hardy, J., & Serri, O. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01679.x · Cited by 300
Coronary artery disease mortality in patients treated for hodgkin's disease
Boivin, J., Hutchison, G. B., Lubin, J. H., & Mauch, P. (1992) · Cancer · doi:10.1002/cncr.2820690528 · Cited by 278
A Nationwide Survey of Mortality in Acromegaly
Kauppinen-Mäkelin, R., Sane, T., Reunanen, A., Välimäki, M. J., Niskanen, L., Markkanen, H., Löyttyniemi, E., Ebeling, T., Jaatinen, P., Laine, H., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1381 · Cited by 269
Bensing, S., Brandt, L., Tabaroj, F., Sjöberg, O., Nilsson, B., Ekbom, A., Blomqvist, P., & Kämpe, O. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03340.x · Cited by 242
Kerrigan, J. R., Veldhuis, J. D., Leyo, S. A., Iranmanesh, A., & Rogol, A. D. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8501158 · Cited by 228
Jenkins, P. J., Bates, P., Carson, M. N., Stewart, P. M., & Wass, J. A. H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1616 · Cited by 221
Self-citationRadiation therapy for pituitary adenoma: Treatment outcome and prognostic factors
Tsang, R. W., Brierley, J. D., Panzarella, T., Gospodarowicz, M. K., Sutcliffe, S. B., & Simpson, W. J. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90941-a · Cited by 216
Barrande, G., Pittino-Lungo, M., Coste, J., Ponvert, D., BERTAGNA, X. Y., LUTON, J. P., & Bertherat, J. Y. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3779 · Cited by 216
The incidence of cerebrovascular accidents in patients with pituitary adenoma
Brada, M., Burchell, L., Ashley, S., & Traish, D. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00159-5 · Cited by 210
Clark, Neylon, Raggatt, Sheppard, & Stewart (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00555.x · Cited by 207
Biermasz, N. R., Dekker, F. W., Pereira, A. M., van Thiel, S. W., Schutte, P. J., van Dulken, H., Romijn, J. A., & Roelfsema, F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032041 · Cited by 193
An assessment of optimal hydrocortisone replacement therapy
Howlett, T. A. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1340955.x · Cited by 169
Pharmacokinetics and Oral Bioavailability of Hydrocortisone
Derendorf, H., Möllmann, H., Barth, J., Möllmann, C., Tunn, S., & Krieg, M. (1991) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1991.tb01906.x · Cited by 168
Continuous subcutaneous hydrocortisone infusion in Addison’s disease
Løvås, K., & Husebye, E. S. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0052 · Cited by 155
Cerebrovascular mortality in patients with pituitary adenoma
Brada, M., Ashley, S., Ford, D., Traish, D., Burchell, L., & Rajan, B. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01570.x · Cited by 150
Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy
Debono, M., Ross, R. J., & Newell-Price, J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0874 · Cited by 135
Why is the management of glucocorticoid deficiency still controversial: a review of the literature
Crown, A., & Lightman, S. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02320.x · Cited by 128
Statistical methods in cancer research
Gardner, B. (2001) · Journal of Surgical Oncology · doi:10.1002/jso.1170.abs · Cited by 122
Modulation of glucocorticoid metabolism by the growth hormone – IGF‐1 axis
Agha, A., & Monson, J. P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02763.x · Cited by 108
Charmandari, E., Johnston, A., Brook, C., & Hindmarsh, P. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690065 · Cited by 104
Cardiovascular risk in Cushing’s syndrome
Arnaldi, G., Mancini, T., Polenta, B., & Boscaro, M. (2004) · Pituitary · doi:10.1007/s11102-005-1172-7 · Cited by 103
Risk Factors for Cerebrovascular Deaths in Patients Operated and Irradiated for Pituitary Tumors
Erfurth, E. M., Bülow, B., Svahn-Tapper, G., Norrving, B., Odh, K., Mikoczy, Z., Björk, J., & Hagmar, L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020526 · Cited by 101
Incidence of cerebral infarction after radiotherapy for pituitary adenoma
Flickinger, J. C., Nelson, P. B., Taylor, F. H., & Robinson, A. (1989) · Cancer · doi:10.1002/1097-0142(19890615)63:12<2404::aid-cncr2820631205>3.0.co;2-3 · Cited by 101
Merza, Z., Rostami‐Hodjegan, A., Memmott, A., Doane, A., Ibbotson, V., Newell‐Price, J., Tucker, G. T., & Ross, R. J. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02544.x · Cited by 98
The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly
Jenkins, D. J. A., O'Brien, I. A. D., Johnson, A., SHAKESPEAR, R. A., Sheppard, M. C., & Stewart, P. M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02913.x · Cited by 87
Self-citationNoad, R., Narayanan, K., Howlett, T. A., Lincoln, N. B., & Page, R. C. (2004) · Clinical Oncology · doi:10.1016/j.clon.2004.01.012 · Cited by 86
Fajardo, L. F. (1999) · Cardiovascular Radiation Medicine · doi:10.1016/s1522-1865(98)00012-2 · Cited by 68
Resection of pulmonary metastases in osteosarcoma. A retrospective analysis of 44 patients
Belli, L., Scholl, S., Livartowski, A., Ashby, M. D., Palangié, T., Levasseur, P., & Pouillart, P. (1989) · Cancer · doi:10.1002/1097-0142(19890615)63:12<2492::aid-cncr2820631222>3.0.co;2-7 · Cited by 65
Groschl, M. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.3.1200 · Cited by 51
Management of nonfunctioning pituitary adenomas.
Sassolas, G., Trouillas, J., Treluyer, C., & Perrin, G. (1993) · PubMed · Cited by 50
Hydrocortisone replacement therapy in children and adolescents with hypopituitarism
DeVile, C. J., & Stanhope, R. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2101025.x · Cited by 41
Dauncey, M. J., SHAKESPEAR, R. A., Rudd, B., & Ingram, D. L. (1990) · Hormone and Metabolic Research · doi:10.1055/s-2007-1004898 · Cited by 33
Pituitary radiotherapy: current controversies
Gittoes, N. J. L. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.09.008 · Cited by 26
Davis, J. R., Sheppard, M. C., SHAKESPEAR, R. A., LYNCH, S. S., & Clayton, R. N. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb00755.x · Cited by 22
Self-citation
Research works printed but not linked: 1
- Fajardo, 1999, Is the pathology of radiation injury different in small vs large blood vessels?, Cardiovasc Radiat Med, 1, 108
Cited by
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
A Consensus Statement on acromegaly therapeutic outcomes
Melmed, S., Bronstein, M. D., Chanson, P., Klibanski, A., Casanueva, F. F., Wass, J. A. H., Strasburger, C. J., Luger, A., Clemmons, D. R., & Giustina, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0058-5 · Cited by 561
Mortality in Patients with Pituitary Disease
Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392
Self-citationA Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
Giustina, A., Barkan, A., Beckers, A., Biermasz, N., Biller, B. M. K., Boguszewski, C., Bolanowski, M., Bonert, V., Bronstein, M. D., Casanueva, F. F., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz096 · Cited by 371
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Gadelha, M. R., Kasuki, L., Lim, D. S. T., & Fleseriu, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00115 · Cited by 363
Metadata
- Authors
- Sherlock, M., Reulen, R. C., Alonso, A. A., Ayuk, J., Clayton, R. N., Sheppard, M. C., Hawkins, M. M., Bates, A. S., & Stewart, P. M.
- Affiliations
- University of Birmingham (GB)
- Centre for Endocrinology, Diabetes and Metabolism (M.S., A.A.A., J.A., M.C.S., P.M.S.), School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, United Kingdom
- Keele University (GB)
- National Health Service (GB)
- Corresponding author
- Stewart, P. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-11-01
- Volume
- 94
- Issue
- 11
- Pages
- 4216-4223
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2079605343
- Semantic Scholar
- 2edc859ca1b96cf7ca9a2a1af8b57d431f6d7a0e
- Cited by
- 185
- References
- 56
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 12 · 2023: 9 · 2022: 11 · 2021: 14 · 2020: 8 · 2019: 10 · 2018: 14 · 2017: 9 · 2016: 22 · 2015: 12 · 2014: 11 · 2013: 10 · 2012: 13
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
- Funders
- Cancer Research UK
- National Institute for Health and Care Research (NF-SI-0508-10356)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Clinical Neurology › Meningioma and schwannoma management
- Keywords
- acromegaly, ACTH deficiency, hydrocortisone replacement, hydrocortisone dose, pituitary radiotherapy, hypopituitarism, gonadotropin deficiency, all-cause mortality, standardized mortality ratio, pituitary adenoma, TSH deficiency, mortality risk factors, long-term follow-up
- MeSH terms
- Acromegaly, Adrenocorticotropic Hormone, Cardiovascular Diseases, Cause of Death, Female, Follow-Up Studies, Humans, Hydrocortisone, Male, Neoplasms, Predictive Value of Tests, Radiotherapy, Respiratory Tract Diseases, Time Factors, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.